The highly-anticipated National Haematology Summit 2022 returned to an in-person event for its eighth year after two virtual iterations, writes Danielle
Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today